Rafael Mella, general manager of Nordic Pharma Spain & Portugal, highlights the steps he has taken to set-up the foundations for the company in the Spanish market and how he has overcome the challenges of the fragmented healthcare system. Furthermore, he gives insight into the Nordic’s game-changing Rheumatoid Arthritis product, NORDiMET®, and the need for Spain to better value incremental innovation in the future.
Here in Spain, we are given the freedom to build our own culture and company within the group; a very attractive proposition for myself and something that has been a pleasure to undertake
